Genomic Testing Cooperative

Home
United States
Lake Forest, CA
Genomic Testing Cooperative

Call Directions Website Contact the practice

State-of-the-art Innovation
Machine/deep Learning meets Next Generation Sequencing

10/28/2026

Two measures. A more complete picture.

VAF shows the percentage of DNA carrying a mutation. Tumor load measures mutant molecules per milliliter. Together, they provide complementary insights into molecular changes over time. GTC’s Liquid Trace reports both.

https://genomictestingcooperative.com/liquid-trace/

10/27/2026

Don't Accept Partial Results
One Bone Marrow Sample. Two Cell Populations. Complete Risk Stratification.
Comprehensive Evaluation for Multiple Myeloma using DNA and RNA Profiling

Learn more: https://genomictestingcooperative.com/genomic-tests/gtc-hematology-profile-plus/

10/26/2026

The Importance of CSF

Cerebrospinal fluid (CSF) can provide valuable molecular information for patients with central nervous system (CNS) malignancies. Comprehensive genomic profiling of CSF may help identify clinically relevant alterations when tissue is limited or when additional molecular insights are needed. GTC's DNA and RNA testing deliver comprehensive genomic information through a single integrated workflow.

https://genomictestingcooperative.com/liquid-trace-on-cerebral-spinal-fluid-csf/

10/23/2026

A clearer picture of liver cancer starts with more information.

This October, for Liver Cancer Awareness Month, we’re highlighting the value of looking at both DNA and RNA. GTC’s Solid Tumor Profile Plus analyzes tumor tissue, while Liquid Trace brings DNA and RNA profiling to a blood sample. Together, these options can help clinicians uncover molecular insights to inform care.

https://genomictestingcooperative.com/genomic-tests/solid-tumor-profile-plus/

10/22/2026

Don’t let QNS/TNP fears stop you from ordering comprehensive genomic profiling.

Using innovative chemistry helps reduce QNS and TNP rates. GTC's QNS rate is currently less than 1%. Most labs using NGS are greater than >10% QNS/TNP

Read more: https://genomictestingcooperative.com/genomic-tests/

10/21/2026

Check out a case study from our talk at SNO-ASCO and how CSF liquid biopsy helped resolve and aid in the classification of a diagnosis.

Check out a case study from our talk at SNO-ASCO and how CSF liquid...

10/20/2026

Similar appearance. Distinct molecular identities.

GTC’s comprehensive DNA + RNA profiling helps classify and characterize cutaneous T-cell lymphomas, revealing molecular insights beyond what appearance alone can tell.

https://genomictestingcooperative.com/genomic-tests/gtc-hematology-profile-plus/

10/19/2026

When cancer affects the CNS, look to CSF for the molecular story.
GTC’s Liquid Trace profiles DNA and RNA in CSF to help characterize primary and metastatic CNS disease.

https://genomictestingcooperative.com/liquid-trace-on-cerebral-spinal-fluid-csf/

10/16/2026

Attending the Binaytara Nashville Hematology event? Stop by our booth to explore GTC’s comprehensive DNA + RNA profiling for hematologic malignancies—including multiple myeloma, lymphoma, leukemia, and MDS.
Learn how we bring together mutations, fusions, clonality, and gene expression to help reveal a more complete molecular picture.
We look forward to connecting!

10/15/2026

At GTC, we believe some of the most meaningful advances in cancer care happen when great science and the right partners come together.

Our newest collaboration with Cerenome brings our comprehensive DNA and RNA sequencing capabilities to its CNSide® platform, helping expand molecular profiling for cancers affecting the central nervous system.

It also builds on longstanding relationships with organizations like Menarini Silicon Biosystems, where our scientific expertise and advanced genomic technologies help support innovation in cancer diagnostics.

As our founder and CEO, Dr. Maher Albitar, puts it: “We don't simply provide genomic testing. We bring scientific expertise, advanced technology and a collaborative approach to solving complex diagnostic challenges.”

We're excited about the partnerships we've built, the new ones taking shape and what we can accomplish together.

Because advancing precision oncology takes more than great technology. It takes great partners.

Address

25371 Commercentre Drive
Lake Forest, CA
92630

Telephone

+19495409421

Website

https://genomictestingcooperative.com/

Alerts

Be the first to know and let us send you an email when Genomic Testing Cooperative posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.